Eric Bjerkholt - Sep 11, 2023 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Sep 11, 2023
Transactions value $
$296,492
Form type
4
Date filed
9/12/2023, 06:23 PM
Previous filing
Aug 23, 2023
Next filing
Dec 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Purchase $296K +10K $29.65 10K Sep 11, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRM Stock Option (right to buy) Award $0 +110K $0.00 110K Sep 11, 2023 Common Stock 110K $30.43 Direct F2
transaction MIRM Restricted Stock Units Award $0 +55K $0.00 55K Sep 11, 2023 Common Stock 55K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported on this Form 4 is a weighted average price. The shares were purchased in multiple transactions ranging from $29.61 to $29.65, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth herein.
F2 1/4th of the shares subject to the Option will vest one year after September 11, 2023 (the "Vesting Commencement Date") and the balance of the shares will vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
F3 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F4 The restricted stock units vest in a series of three successive equal annual installments beginning on the one year anniversary of September 11, 2023.